Quantitative Evaluation of HIV-1 Coreceptor Use in the GHOST(3) Cell Assay

Dalma Vödrös; Charlotte Tscherning-Casper; Leonor Navea; Dominique Schols; De Clercq Erik; Éva Mária Fenyõ

doi:10.1006/viro.2001.1163

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1989

Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds

Hideki Nakashima, Rudi Pauwels, Masanori Baba, Dominique Schols, Jan Desmyter, De Clercq Erik

Article2003

Development of a Cell-Based Enzyme-Linked Immunosorbent Assay for High-Throughput Screening of HIV Type 1 Entry Inhibitors Targeting the Coreceptor CXCR4

Qian Zhao, Hong Lü, Dominique Schols, De Clercq Erik, Shibo Jiang

Article1999

Coreceptor Ligand Inhibition of Fetal Brain Cell Infection by HIV Type 1

Sam Hibbitts, Jacqueline D. Reeves, Graham Simmons, Patrick W. Gray, Leon G. Epstein, Dominique Schols, De Clercq Erik, Timothy N. C. Wells, Amanda E. I. Proudfoot, Paul R. Clapham

Article2002

Establishment of an in vitro assay system for HIV-1-induced neural cell death and inhibition thereof

Mitsumasa Okamoto, X Wang, Zeger Debyser, De Clercq Erik, Masanori Baba

Editorial Material2020

Use a “GHOST-CAP” in acute brain injury

Fabio Silvio Taccone, Airton Leonardo de Oliveira Manoel, Chiara Robba, Jean Louis Vincent